Cortical high-threshold and low-activation characteristics in adolescent depression: a cross-age differential analysis - Scorecard - MDSpire

Cortical high-threshold and low-activation characteristics in adolescent depression: a cross-age differential analysis

  • By

  • Jialin Gai

  • Duanwei Wang

  • Fengya Zhen

  • Tao Kong

  • Xiuqing Niu

  • Xianwei Che

  • Shengqiao Wang

  • Zhe Liu

  • Cuixia An

  • Xu Lin

  • May 14, 2026

  • 0 min

Share

Clinical Scorecard: Cortical Activation Patterns and Threshold Levels in Adolescent Depression: An Analysis Across Different Age Groups

At a Glance

CategoryDetail
Condition
Key MechanismsCortical excitability and resting motor threshold (RMT) measured during rTMS and fNIRS.
Target Population
Care Setting

Key Highlights

  • Adolescents exhibit significantly higher RMT compared to young adults and middle-aged groups.
  • Lower prefrontal Oxy-Hb activation levels correlate with higher RMT in adolescents.
  • Strong negative correlation between RMT and cortical activation.
  • Positive correlation between RMT and depression severity.
  • Findings suggest a need for tailored neuromodulation strategies in adolescent depression.
  • Age-specific RMT values are crucial for safe rTMS application.

Guideline-Based Recommendations

Diagnosis

  • Utilize HAMD for assessing depression severity in adolescents.

Management

  • Consider individualized rTMS parameters based on RMT and cortical activation levels.
  • Incorporate fNIRS data in treatment planning.

Monitoring & Follow-up

  • Regularly assess changes in RMT and cortical activation during treatment.

Risks

  • Excessive stimulation may occur if adult RMT values are applied to adolescents.

Patient & Prescribing Data

Treatment-naive adolescents with depression.

High RMT and low cortical activation are neurobiological markers for severity.

Clinical Best Practices

  • Prioritize the integration of emotional circuits in treatment strategies.
  • Adjust rTMS dosages based on age-specific RMT distributions.
  • Monitor neurophysiological markers, including fNIRS data, to optimize therapeutic efficacy.

Related Resources & Content

Original Source(s)

Related Content